CompletedPhase 2NCT00506688
Efficacy and Safety Study of Inhaled Glutathione in Cystic Fibrosis Patients
Studying Cystic fibrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mukoviszidose Institut gGmbH
- Principal Investigator
- Matthias Griese, Prof.Dr. von Haunersches Kinderspital (University of Munich, Germany)
- Intervention
- reduced glutathione sodium salt(drug)
- Enrollment
- 153 enrolled
- Eligibility
- 8 years · All sexes
- Timeline
- 2007 – 2010
Study locations (14)
- Charité Campus Virchow Klinikum,Klinik für Pädiatrie, Berlin, Germany
- Universitätskinderklinink, Bochum, Germany
- Uniklinik Köln Mukoviszidose Zentrum, Cologne, Germany
- Ruhrlandklinink, Essen, Germany
- CF-Ambulanz/ Universitätsklinikum Essen, Essen, Germany
- CF-Ambulanz Frankfurt, Frankfurt, Germany
- Universitätsklinikum Freiburg, Freiburg im Breisgau, Germany
- Gemeinschaftspraxis CF Ambulanz, Hamburg, Germany
- Med. Hochschule Hannover, Hanover, Germany
- MHH Kinderklinik CF-Ambulanz, Hanover, Germany
- Universitätsklinik, Leipzig, Germany
- CF-Amulanz/ Dr.von Haunersches Kinderspital, Munich, Germany
- Klinikum Innenstadt, Medizinische Klinik / Pneumologie, München, Germany
- Clemenshospital GmbH,Akademisches Lehrkrankenhaus der Westfälischen Wildhelms-Universität Münster, Münster, Germany
Collaborators
Cystic Fibrosis Foundation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00506688 on ClinicalTrials.govOther trials for Cystic fibrosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT04530383Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel FunctionUniversity of Kansas Medical Center
- RECRUITINGPHASE2NCT07450547Phase 2 Study to Assess the Safety and Efficacy of ANG003Anagram Therapeutics, Inc.
- RECRUITINGPHASE1NCT07437105Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy ParticipantsVertex Pharmaceuticals Incorporated
- RECRUITINGNANCT07436351ACT With CF Self-Help ToolkitThomas Jefferson University
- RECRUITINGNANCT07314229Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-IvacaftorUniversity Hospital, Lille
- RECRUITINGNCT07083557Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)Bettina Mittendorfer
- RECRUITINGNCT07369414Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure Risk at HomeResearch Center Borstel
- RECRUITINGNCT07505797ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)iSono Health, Inc.